After attending several virtual scientific conferences since the start of the COVID-19 lockdown, TBWA\WorldHealth explores which practices should stay, which ones will need to come back, and how pharmaceutical brands can stand out in this medium.

A review of recently published scientific studies includes a look at the potential of using flu and pneumonia vaccines to decrease the risk of developing Alzheimer’s disease.

Decentralized clinical trials gained a foothold in the pharmaceutical industry amidst the COVID-19 pandemic and will continue to be used once the pandemic ends, according to panelists at BIO 2020.

Biopharmaceutical companies need to look beyond the usual targets when addressing neurodegenerative disorders and also must work to correlate genetic changes to cognitive changes in patients, according to panelists at BIO’s on-demand session, “Battle of the Brains: Rethinking Neurodegenerative Disease Treatment.”

BIO 2020: Day 1 Kicked Off With New CEO, Focus on COVID-19 Published: June 9, 2020 By Alex Keown BioSpace   The annual Biotechnology Innovation Organization (BIO) meeting kicked off Monday with the proverbial passing of the baton from longtime head Jim Greenwood to Michelle McMurry-Heath, who was tapped to take over the organization last month. […]

One day, cell and gene therapies will be as common as small molecules and antibody-based therapies are today, according to panelists at BIO 2020.

Greater Than One’s Christa Toole analyzes how healthcare marketers are adjusting to the current health crisis in a variety of ways.

The Biotechnology Innovation Organization (BIO)’s annual meeting brings together some of the brightest minds across the industry to showcase advancements in developing therapeutics that will benefit people battling a myriad of diseases. The 2020 event, which kicks off June 8, will have a different look as an entirely digital conference.

Businesses, professional bodies and individual practitioners have to keep talking at a time like this, not least because patients’ non-Covid-related needs have not disappeared overnight. How are lines of communication holding up, and what might this tell us about life after Covid-19?

Seemingly in response to global uncertainty over the coronavirus outbreak, the stock markets have plunged, numerous conferences are being canceled and biopharma companies are taking action.